GSK256073

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GSK256073, covering 2017-06-14 to 2017-10-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin [Phase 2]